EN DE

Crawford & Company (CRD-B) Fair Value & Analysis

Financial Services · US · Market cap $593M

CC Crawford & Company logo Crawford & Company CRD-B · US
Price$12.47
Fair Value$4.97
Upside-60.1%
Quality60/100
Watch Crawford & Company for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 1.9% net margin
Moderate debt · generates free cash flow
2.46% dividend yield
Trails peers (5/15)
Moderate moat 45/100
Evidence: High Range $3.73 – $6.21 Share as image

Fair value as of: Aug 17, 2026

From 6 valuation models · updated today

Share price +23.6% over the past month.

A solid business, but screening 60% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case ($6.21). The favourable scenario is already priced in.
  • Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder.
  • For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$12.47 $4.55 Fair Value $4.97 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 17, 2026.

How to read this chart

60‑month range $4.55 – $12.47 · fair‑value band $3.73 – $6.21 · the $12.47 price screens above the $4.97 fair value. Dashed = 300-day average. As of Aug 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Crawford & Company (CRD-B) currently trades at $12.47, while our model-based Fair Value estimate is $4.97, implying the stock looks roughly 60.1% overvalued today. The Quality Score stands at 60/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Crawford & Company generated revenue of $1.3B at a net margin of 1.4%. Revenue declined 0.8% year over year. It earns a return on equity of 10.7%. Net debt stands at $206M. Fundamentals as of Aug 17, 2026

Our scenario range runs from $3.73 (bear case) to $6.21 (bull case); at $12.47, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 47% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -41% fair-value upside, at -60%, CRD-B screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Residual Income $2.99 $3.31 $4.33 76
Gordon GGM $2.22 $2.93 $3.58 70
P/E Multiple $3.82 $5.10 $6.37 63
All 6 models by family
Dividend Discount
Gordon GGM $2.22 $2.93 $3.58 70
DDM Multi-Stage $2.22 $2.93 $3.66 61
Multiples
P/E Multiple $3.82 $5.10 $6.37 63
P/B Multiple $3.63 $4.84 $6.05 55
Asset-Based
NCAV (Graham) $1.73 $2.32 $3.46 50
Economic Profit
Residual Income $2.99 $3.31 $4.33 76

Widest divergence: Multiples ($4.84) versus Asset-Based ($2.32). Highest evidence: Residual Income (76).

Notify me when CRD-B reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $1.3B
Revenue growth (YoY) -0.8%
Net margin 1.4%
Return on equity 10.7%
Free cash flow $94.8M FY2025
P/E ratio 28.9 as of Jun 19, 2026
More key figures
Operating margin 3.2%
EPS (TTM) $0.3600
Dividend yield 2.9%
EPS growth (YoY) -25.9%
Net debt $206M FY2025

Figures from reported company fundamentals · as of Aug 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 60/100

Of which business quality 56 · Market factors (momentum, volatility) 73

Profitability 55
Margins and returns on capital today
Quality Growth 39
Are margins and returns improving?
Cashflow 69
Earnings quality: real cash, not paper profit
Fin. Strength 31
Balance sheet, leverage, solvency risk
Investment 81
Disciplined investing over empire-building
Low Volatility 69
Calm price path (market factor)
Momentum 68
Price trend over the last 3–12 months (market factor)
52W Momentum 85
Distance to the 52-week high (market factor)
Net Issuance 76
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Crawford & Company provides claims management and outsourcing solutions for carriers, brokers, and corporations in the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America.

Full company description

Crawford & Company provides claims management and outsourcing solutions for carriers, brokers, and corporations in the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America. The company provides claims management services to insurance carriers and self-insured entities risk, including property, public liability, automobile liability, and marine insurance; claims management and adjusting services to insurance carriers and self-insured entities from property and casualty insurance company markets; and field investigation and the evaluation and resolution of property and casualty insurance claims. It also offers claims management services, including workers' compensation, liability, and property; death and dismemberment, business travel, life, disability, critical illness, and credit protection claims programs; short and long term disability, family medical leave act, Americans with disabilities act, and state leave claims; legal services, risk management information, and consultative analytical services; loss mitigation services, such as medical bill review, medical case management and vocational rehabilitation; risk management information services; and administration of loss funds established to pay claims. In addition, the company provides managed repair service and outsourced contractor management to national and regional personal and commercial insurance carriers; services to insurance companies on losses caused by all types of natural disasters comprising fires, hailstorms, hurricanes, earthquakes, floods, as well as man-made disasters, such as oil spills, chemical releases, and explosions; staff augmentation that provides temporary staffing resources; and outsourced subrogation claims management, recovery, and consultative services for the property and casualty insurance industry. Crawford & Company was founded in 1941 and is headquartered in Atlanta, Georgia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Crawford & Company reported revenue of $1.3B in FY2025 versus $1.1B in FY2021, a compound +3.6%/yr. Reported net income was $19.6M in FY2025, compounding −10.6%/yr from FY2021.

Growth Quality 64/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$1.3B
Latest YoY
−2.0%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+2.2%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.3%
Avg. growth/yr (40Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.6%
Revenue +3.6%/yr
FY21 $1.1B
FY22 $1.2B
FY23 $1.3B
FY24 $1.3B
FY25 $1.3B
Net income −10.6%/yr
FY21 $30.7M
FY22 −$18.3M
FY23 $30.6M
FY24 $26.6M
FY25 $19.6M
Character of growth · EPS growth decomposed (2014-2025) −2.1 % p.a.
Revenue per share +2.0 pp

of which total revenue +1.1 pp · buybacks/dilution +0.9 pp

EBIT margin −1.2 pp
Tax rate +1.4 pp
Residual (interest, one-offs) −4.2 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

CRD-B screens 60% overvalued. Compare with Marsh & McLennan Companies, Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Crawford & Company Fair Value". https://www.fairvalue-calculator.com/stock/CRD-B

Peer Group

Insurance Brokers · 36 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 58 · Below median
Fair Value upside −60% · Below median
Return on equity (TTM) 13% · Below median
Return on assets 5% · Above median
Net margin (TTM) 2% · Bottom 25%
Operating margin (TTM) 7% · Below median
Revenue growth -1% · Bottom 25%
Dividend yield (TTM) 2.5% · Below median
Debt / equity 0.87× · Higher than 75% of peers

Valuation Multiples vs Insurance Brokers median · lower = cheaper

P/E (TTM) 28.9× · Pricier than 75% of peers
P/B 3.43× · Pricier than median
P/S (TTM) 0.47× · Cheaper than 75% of peers
P/FCF 6.3× · Cheaper than median
EV/EBITDA 8.5× · Cheaper than median
PEG 0.90× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 0 · sector 53
PAST 52 · sector 60
HEALTH 57 · sector 91
DIVIDEND 49 · sector 75

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Insurance Brokers stocks, each showing price versus our Fair Value estimate (as of Aug 17, 2026).

Stock Price Fair Value vs Fair Value
Marsh & McLennan Companies, Inc MRSH $188.86 $112.25 -41%
Aon plc AON $352.36 $224.91 -36%
Arthur J. Gallagher & Co AJG $255.46 $75.58 -70%
Willis Towers Watson Public Limited WTW $340.29 $220.92 -35%
Brown & Brown, Inc BRO $71.06 $40.43 -43%
Erie Indemnity Company ERIE $256.64 $113.32 -56%
PB Fintech Limited POLICYBZR ₹1,739 ₹204.86 -88%
Neptune Insurance Holdings NP $30.77 $3.52 -89%
Steadfast Group SDF A$5.27 A$3.92 -26%
CorVel Corporation CRVL $62.75 $39.55 -37%

Compare Crawford & Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Crawford & Company (CRD-B) overvalued or undervalued?
As of Aug 17, 2026, our model estimates a fair value of $4.97 versus a price of $12.47, about −60% (overvalued).
What is the fair value of CRD-B?
Our model-based fair value for Crawford & Company is $4.97 (as of Aug 17, 2026), built from audited fundamentals. The current price is $12.47.
What is the quality score of CRD-B?
Crawford & Company has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Crawford & Company (CRD-B)?
Crawford & Company reported trailing-twelve-month revenue of about $1.3B (latest available figure, as of Aug 17, 2026).
What is the net profit margin of CRD-B?
The net profit margin of Crawford & Company is about 1.4%, meaning it keeps roughly 1.4% of revenue as net income. Based on the latest reported figures.
Does Crawford & Company pay a dividend?
Crawford & Company currently shows a dividend yield of about 2.86% relative to its recent price (as of Aug 17, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Crawford & Company and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.